Antibody-Drug Conjugates Are Creating a Distinct Regulatory Affairs Hiring Niche
ADCs combine biologic and small-molecule review questions in one submission. Here's why that is creating a specialized regulatory affairs hiring niche.
171 articles for regulatory affairs professionals in pharma, biotech and medical devices: career guidance, role profiles, hiring trends and policy explainers. Updated Oct 10, 2026.
5,000+ job seekers
joined our newsletter
Showing 13–24 of 32 articles
ADCs combine biologic and small-molecule review questions in one submission. Here's why that is creating a specialized regulatory affairs hiring niche.
How ongoing nitrosamine impurity risk assessment and remediation work is creating steady, specialized CMC regulatory affairs hiring demand across pharma.
Why contract manufacturers need a different flavor of regulatory affairs talent than sponsors do, and what that means for job seekers weighing a move.
Why blood and plasma-derived therapies are becoming a distinct regulatory affairs hiring niche, what the work involves, and how it differs from typical biologics roles.
Why point-of-care and at-home diagnostics are becoming a distinct regulatory hiring niche, and what CLIA waiver and usability expertise employers look for.
Real-world evidence is moving from a supporting exhibit to a core part of regulatory submissions, and it's creating a distinct regulatory affairs hiring niche.
Why companion diagnostics work is becoming its own regulatory specialty, what the hiring market looks like, and how to position yourself for dual-track roles.
Why 503A and 503B compounding pharmacy regulation is creating a distinct, growing regulatory affairs hiring niche, and what the work looks like day to day.
FDA's 2020 OTC monograph reform created a faster administrative pathway and a distinct kind of regulatory affairs work. What the niche involves and who is hiring.
The GLP-1 and metabolic drug boom is reshaping regulatory affairs hiring. What the demand looks like and which skills it actually rewards.
Radioligand therapy programs are creating a distinct regulatory affairs hiring niche. What the work involves and why experienced talent is scarce.
Generic drug regulatory work is a large, steady, and often overlooked hiring niche. Here is what ANDA-focused roles involve and who they suit.